COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
The USA market for Global COVID-19 Molecular Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global COVID-19 Molecular Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global COVID-19 Molecular Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report contains market size and forecasts of COVID-19 Molecular Diagnostics in Global, including the following market information:
- Global COVID-19 Molecular Diagnostics Market Size 2024-2030, ($ millions)
- The global COVID-19 Molecular Diagnostics market is projected to reach US$ million by 2029.
We surveyed the COVID-19 Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Molecular Diagnostics Market, by Type, 2024-2030 ($ millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by Type
- High-throughput Sequencing
- Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
- Immunological Detection
Global COVID-19 Molecular Diagnostics Market, by Application, 2024-2030 ($ millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by Application
- Hospitals
- Scientific Research
- Biodiagnostics
Global COVID-19 Molecular Diagnostics Market, By Region and Country, 2024-2030 ($ Millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by region and country
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Henry Schein
- Safecare Bio-Tech
- Thermo Fisher
- Bio-rad
- Agilent
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- QIAGEN
- Bioer
- Biosynex
- Esco
- Analytik Jena
- Techne
- Da An Gene
- BGI
- Shanghai ZJ Bio-Tech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ipilimumab, market overview.
Chapter 2: Global COVID-19 Molecular Diagnostics market size in revenue and volume.
Chapter 3: Detailed analysis of COVID-19 Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of COVID-19 Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global COVID-19 Molecular Diagnostics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Molecular Diagnostics Overall Market Size
2.1 Global COVID-19 Molecular Diagnostics Market Size: 2023 VS 2030
2.2 Global COVID-19 Molecular Diagnostics Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Molecular Diagnostics Players in Global Market
3.2 Global Companies COVID-19 Molecular Diagnostics Product & Technology
4 COVID-19 Molecular Diagnostics Companies Profiles
4.1 Cellex
4.1.1 Cellex Company Summary
4.1.2 Cellex Business Overview
4.1.3 Cellex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.1.4 Cellex COVID-19 Molecular Diagnostics R&D, and Plans
4.2 Abbott
4.2.1 Abbott Company Summary
4.2.2 Abbott Business Overview
4.2.3 Abbott COVID-19 Molecular Diagnostics Product Offerings & Technology
4.2.4 Abbott COVID-19 Molecular Diagnostics R&D, and Plans
4.3 Roche
4.3.1 Roche Company Summary
4.3.2 Roche Business Overview
4.3.3 Roche COVID-19 Molecular Diagnostics Product Offerings & Technology
4.3.4 Roche COVID-19 Molecular Diagnostics R&D, and Plans
4.4 BioMedomics
4.4.1 BioMedomics Company Summary
4.4.2 BioMedomics Business Overview
4.4.3 BioMedomics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.4.4 BioMedomics COVID-19 Molecular Diagnostics R&D, and Plans
4.5 BD
4.5.1 BD Company Summary
4.5.2 BD Business Overview
4.5.3 BD COVID-19 Molecular Diagnostics Product Offerings & Technology
4.5.4 BD COVID-19 Molecular Diagnostics R&D, and Plans
4.6 Henry Schein
4.6.1 Henry Schein Company Summary
4.6.2 Henry Schein Business Overview
4.6.3 Henry Schein COVID-19 Molecular Diagnostics Product Offerings & Technology
4.6.4 Henry Schein COVID-19 Molecular Diagnostics R&D, and Plans
4.7 Safecare Bio-Tech
4.7.1 Safecare Bio-Tech Company Summary
4.7.2 Safecare Bio-Tech Business Overview
4.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
4.8 Thermo Fisher
4.8.1 Thermo Fisher Company Summary
4.8.2 Thermo Fisher Business Overview
4.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings & Technology
4.8.4 Thermo Fisher COVID-19 Molecular Diagnostics R&D, and Plans
4.9 Bio-rad
4.9.1 Bio-rad Company Summary
4.9.2 Bio-rad Business Overview
4.9.3 Bio-rad COVID-19 Molecular Diagnostics Product Offerings & Technology
4.9.4 Bio-rad COVID-19 Molecular Diagnostics R&D, and Plans
4.10 Agilent
4.10.1 Agilent Company Summary
4.10.2 Agilent Business Overview
4.10.3 Agilent COVID-19 Molecular Diagnostics Product Offerings & Technology
4.10.4 Agilent COVID-19 Molecular Diagnostics R&D, and Plans
4.11 Ortho Clinical Diagnostics
4.11.1 Ortho Clinical Diagnostics Company Summary
4.11.2 Ortho Clinical Diagnostics Business Overview
4.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.12 Zhejiang Orient Gene Biotech
4.12.1 Zhejiang Orient Gene Biotech Company Summary
4.12.2 Zhejiang Orient Gene Biotech Business Overview
4.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.13 Innovita Biological Technology
4.13.1 Innovita Biological Technology Company Summary
4.13.2 Innovita Biological Technology Business Overview
4.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings & Technology
4.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics R&D, and Plans
4.14 Guangzhou Wondfo Biotech
4.14.1 Guangzhou Wondfo Biotech Company Summary
4.14.2 Guangzhou Wondfo Biotech Business Overview
4.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.15 Guangdong Hecin-Scientific
4.15.1 Guangdong Hecin-Scientific Company Summary
4.15.2 Guangdong Hecin-Scientific Business Overview
4.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings & Technology
4.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics R&D, and Plans
4.16 Dynamiker Biotechnology (Tianjin)
4.16.1 Dynamiker Biotechnology (Tianjin) Company Summary
4.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
4.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings & Technology
4.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics R&D, and Plans
4.17 ADVAITE
4.17.1 ADVAITE Company Summary
4.17.2 ADVAITE Business Overview
4.17.3 ADVAITE COVID-19 Molecular Diagnostics Product Offerings & Technology
4.17.4 ADVAITE COVID-19 Molecular Diagnostics R&D, and Plans
4.18 Mayo Clinic Laboratories
4.18.1 Mayo Clinic Laboratories Company Summary
4.18.2 Mayo Clinic Laboratories Business Overview
4.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings & Technology
4.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics R&D, and Plans
4.19 Chembio Diagnostics
4.19.1 Chembio Diagnostics Company Summary
4.19.2 Chembio Diagnostics Business Overview
4.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.20 Mount Sinai Laboratory
4.20.1 Mount Sinai Laboratory Company Summary
4.20.2 Mount Sinai Laboratory Business Overview
4.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings & Technology
4.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics R&D, and Plans
4.21 QIAGEN
4.21.1 QIAGEN Company Summary
4.21.2 QIAGEN Business Overview
4.21.3 QIAGEN COVID-19 Molecular Diagnostics Product Offerings & Technology
4.21.4 QIAGEN COVID-19 Molecular Diagnostics R&D, and Plans
4.22 Bioer
4.22.1 Bioer Company Summary
4.22.2 Bioer Business Overview
4.22.3 Bioer COVID-19 Molecular Diagnostics Product Offerings & Technology
4.22.4 Bioer COVID-19 Molecular Diagnostics R&D, and Plans
4.23 Biosynex
4.23.1 Biosynex Company Summary
4.23.2 Biosynex Business Overview
4.23.3 Biosynex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.23.4 Biosynex COVID-19 Molecular Diagnostics R&D, and Plans
4.24 Esco
4.24.1 Esco Company Summary
4.24.2 Esco Business Overview
4.24.3 Esco COVID-19 Molecular Diagnostics Product Offerings & Technology
4.24.4 Esco COVID-19 Molecular Diagnostics R&D, and Plans
4.25 Analytik Jena
4.25.1 Analytik Jena Company Summary
4.25.2 Analytik Jena Business Overview
4.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product Offerings & Technology
4.25.4 Analytik Jena COVID-19 Molecular Diagnostics R&D, and Plans
4.26 Techne
4.26.1 Techne Company Summary
4.26.2 Techne Business Overview
4.26.3 Techne COVID-19 Molecular Diagnostics Product Offerings & Technology
4.26.4 Techne COVID-19 Molecular Diagnostics R&D, and Plans
4.27 Da An Gene
4.27.1 Da An Gene Company Summary
4.27.2 Da An Gene Business Overview
4.27.3 Da An Gene COVID-19 Molecular Diagnostics Product Offerings & Technology
4.27.4 Da An Gene COVID-19 Molecular Diagnostics R&D, and Plans
4.28 BGI
4.28.1 BGI Company Summary
4.28.2 BGI Business Overview
4.28.3 BGI COVID-19 Molecular Diagnostics Product Offerings & Technology
4.28.4 BGI COVID-19 Molecular Diagnostics R&D, and Plans
4.29 Shanghai ZJ Bio-Tech
4.29.1 Shanghai ZJ Bio-Tech Company Summary
4.29.2 Shanghai ZJ Bio-Tech Business Overview
4.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Molecular Diagnostics Market Size, 2024 & 2030
5.2 By Region - Global COVID-19 Molecular Diagnostics Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of COVID-19 Molecular Diagnostics in United States
5.3.2 United States COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Molecular Diagnostics in Europe
5.4.2 Europe COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Molecular Diagnostics in China
5.5.2 China COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 Molecular Diagnostics Market Size Markets, 2024 & 2030
6.2 High-throughput Sequencing
6.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
6.4 Immunological Detection
7 Sights by Application
7.1 By Application - Global COVID-19 Molecular Diagnostics Market Size, 2024 & 2030
7.2 Hospitals
7.3 Scientific Research
7.4 Biodiagnostics
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. COVID-19 Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Molecular Diagnostics Market Drivers in Global Market
Table 3. COVID-19 Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Molecular Diagnostics in Global Market
Table 5. Global Companies COVID-19 Molecular Diagnostics Product & Technology
Table 6. Cellex Company Summary
Table 7. Cellex COVID-19 Molecular Diagnostics Product Offerings
Table 8. Abbott Company Summary
Table 9. Abbott COVID-19 Molecular Diagnostics Product Offerings
Table 10. Roche Company Summary
Table 11. Roche COVID-19 Molecular Diagnostics Product Offerings
Table 12. BioMedomics Company Summary
Table 13. BioMedomics COVID-19 Molecular Diagnostics Product Offerings
Table 14. BD Company Summary
Table 15. BD COVID-19 Molecular Diagnostics Product Offerings
Table 16. Henry Schein Company Summary
Table 17. Henry Schein COVID-19 Molecular Diagnostics Product Offerings
Table 18. Safecare Bio-Tech Company Summary
Table 19. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 20. Thermo Fisher Company Summary
Table 21. Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings
Table 22. Bio-rad Company Summary
Table 23. Bio-rad COVID-19 Molecular Diagnostics Product Offerings
Table 24. Agilent Company Summary
Table 25. Agilent COVID-19 Molecular Diagnostics Product Offerings
Table 26. Ortho Clinical Diagnostics Company Summary
Table 27. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 28. Zhejiang Orient Gene Biotech Company Summary
Table 29. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 30. Innovita Biological Technology Company Summary
Table 31. Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings
Table 32. Guangzhou Wondfo Biotech Company Summary
Table 33. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 34. Guangdong Hecin-Scientific Company Summary
Table 35. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings
Table 36. Dynamiker Biotechnology (Tianjin) Company Summary
Table 37. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings
Table 38. ADVAITE Company Summary
Table 39. ADVAITE COVID-19 Molecular Diagnostics Product Offerings
Table 40. Mayo Clinic Laboratories Company Summary
Table 41. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings
Table 42. Chembio Diagnostics Company Summary
Table 43. Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 44. Mount Sinai Laboratory Company Summary
Table 45. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings
Table 46. QIAGEN Company Summary
Table 47. QIAGEN COVID-19 Molecular Diagnostics Product Offerings
Table 48. Bioer Company Summary
Table 49. Bioer COVID-19 Molecular Diagnostics Product Offerings
Table 50. Biosynex Company Summary
Table 51. Biosynex COVID-19 Molecular Diagnostics Product Offerings
Table 52. Esco Company Summary
Table 53. Esco COVID-19 Molecular Diagnostics Product Offerings
Table 54. Analytik Jena Company Summary
Table 55. Analytik Jena COVID-19 Molecular Diagnostics Product Offerings
Table 56. Techne Company Summary
Table 57. Techne COVID-19 Molecular Diagnostics Product Offerings
Table 58. Da An Gene Company Summary
Table 59. Da An Gene COVID-19 Molecular Diagnostics Product Offerings
Table 60. BGI Company Summary
Table 61. BGI COVID-19 Molecular Diagnostics Product Offerings
Table 62. Shanghai ZJ Bio-Tech Company Summary
Table 63. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 64. By Region? Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2024 & 2030
Table 65. By Region - Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 66. By Type ? Global COVID-19 Molecular Diagnostics Market Size, (US$, Mn), 2024 & 2030
Table 67. By Application? Global COVID-19 Molecular Diagnostics Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. COVID-19 Molecular Diagnostics Segment by Type in 2030
Figure 2. COVID-19 Molecular Diagnostics Segment by Application in 2030
Figure 3. Global COVID-19 Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Molecular Diagnostics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global COVID-19 Molecular Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2024-2030
Figure 8. By Type - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2024-2030
Figure 9. By Application - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2024-2030
